Schizophrenia Research

Article	Citations
Issue Highlights	76
Binaural hearing impairment in patients with schizophrenia: A multicenter study	62
Creating a collaborative culture of learning within a network of community mental health early psychosis programs in Texas	60
The effectiveness of adjunctive cariprazine for treatment of negative symptoms: A systematic review of randomised controlled trials	55
Psychopathology trajectories and relapse in first episode schizophrenia with assured long-acting injectable adherence over 24 months	55
Sex-specific associations between sex hormones and clinical symptoms in late-life schizophrenia	54
Recovery from leukopenia after discontinuation of clozapine does not exclude lymphoma	52
Issue Highlights	49
Insomnia and aggression in stable schizophrenic patients: The mediating role of quality of life	47
Home-based transcranial direct current stimulation in schizophrenia: Systematic literature review, a teenager case report with cost-utility analysis	46
Exploring phenotypic overlap across schizotypy and autism spectrum conditions in American and Chinese young adults	45
Reduced task-evoked pupillary response in preparation for an executive cognitive control response among individuals across the psychosis spectrum	44
Digital health interventions for schizophrenia: Setting standards for mental health	44
Impact of loneliness and living alone on negative symptoms in severe mental illness: An electronic health record data analysis	44
Impact of long-acting injectable antipsychotics in early psychosis: An umbrella review	43
Sex differences and age of onset in well-being and recovery in people with psychotic disorders. A PHAMOUS study	40
Going the extra mile? The influence of Amisulpride on effort-based decisions	40
In this issue	39
Scrutinizing the increased mortality risk associated with the use of typical oral antipsychotics	39
Editorial Board	36
Epistatic interactions of NRG1 and ERBB4 on antipsychotic treatment response in first-episode schizophrenia patients	36
The role of antipsychotics against COVID-19: A topic for debate	35
Identification of ultra-rare missense mutations associated with familial schizophrenia by whole-exome sequencing	35
Tardive dyskinesia's under-recognition in the era of COVID-19	34
Issue highlights	33

Issue highlights	33
The dimensionality of perceptual anomalies and their relationships with bullying victimization among Chinese adolescents: From a network perspective	32
Short-term intake of amisulpride does not alter psychobiological stress responses. A randomized, double-blind, placebo-controlled paradigm using a standardized stressor	32
Understanding the effect of various factors on clozapine serum levels in Indian population	32
The dilemma of self vs others' interest: Altruistic behaviour in schizophrenia and the role of vasopressin	31
Risk factors for suicidality across psychosis vulnerability spectrum	31
Editorial Board	31
Stem cell transplant in psychotic disorders: Immunological cause or cure?	31
Editorial Board	30
Parakinesia: A Delphi consensus report	30
Towards a temporospatial framework for measurements of disorganization in speech using semantic vectors	29
Editorial Board	28
Editorial Board	27
Psychotic experiences and mental health outcomes in the general population: The Lolland-Falster Health Study	27
In this issue	27
A detailed examination of pitch discrimination deficits associated with auditory verbal hallucinations in schizophrenia	27
COVID-19 vaccination among patients with schizophrenia prescribed clozapine	26
Is preventing the second psychotic episode a disease-modifying strategy for schizophrenia?	25
Comorbid psychosis in temporal lobe epilepsy is associated with auditory emotion recognition impairments	25
Editorial Board	24
Psychotic behaviors during COVID-19: Should conspiracist ideation be included within the continuum model of psychosis?	24
Issue highlights	24
A proposal definition criteria for psychotic relapse: Filling the gap for real-world studies	23
Editorial Board	23
Symptomatic remission and recovery in major psychosis: Is there a role for BDNF? A secondary analysis of the LABSP cohort data	23
Editorial Board	22
Editorial Board	22
Impaired migration of autologous induced neural stem cells from patients with schizophrenia and implications for genetic risk for psychosis	22
A profile of high scores on the Peters delusion inventory and low engagement in pandemic-related health behaviors in a non-clinical sample	22
Association between incarceration and psychotic experiences in a general population sample	22
Emotion regulation strategies and suicidal ideation among individuals with first-episode psychosis	22
How voices change the brain. Two fMRI follow-up case reports	22
Editorial Board	22
Social media in screening and monitoring for early intervention in psychosis	21
Selection bias in clinical studies of first-episode psychosis: A follow-up study	21
Impact of coping styles on substance use in persons with psychosis, siblings, and controls	20
No association between advanced paternal age and age of onset of illness among patients with schizophrenia: A cross-sectional study from South India	20
Real-time facial emotion recognition deficits across the psychosis spectrum: A B-SNIP Study	20
Metabolic polygenic risk scores effect on antipsychotic-induced metabolic dysregulation: A longitudinal study in a first episode psychosis cohort	19
Comparison of two cognitive screening measures in a longitudinal sample of youth at-risk for psychosis	19
Comparative predictive efficacy of atherogenic indices on metabolic syndrome in patients with schizophrenia	19
Clozapine in treatment-resistant schizophrenia: Reflections from the Hallmark US clinical trial and beyond	19
Prospective, randomized, multicenter clinical trial evaluating longitudinal changes in brain function and microstructure in first-episode schizophrenia patients treated with long-acting injectable pal	19
A bioinformatic inquiry of the EAAT2 interactome in postmortem and neuropsychiatric datasets	19
Meta-analysis of clozapine and insomnia in schizophrenia	19
An expert review of clozapine in Eastern European countries: Use, regulations and pharmacovigilance	19
Can clozapine be used for treatment-refractory behavioral and psychological symptoms in dementia patients?	19
Predictors of relapse and engagement in care one year after ending services in an urban safety net coordinated specialty care program for first episode psychosis	19
Progressive neurocognitive decline in schizophrenia: A diagnostic dilemma for clinicians	18
Exploring associations between trait symptoms and speech patterns in schizophrenia spectrum disorders: A mediation analysis	18

Serum total cholesterol levels associated with immediate memory performance in patients with chronic schizophrenia	18
Across the continuum: Associations between (fluctuations in) momentary self-esteem and psychotic experiences	18
Issue Highlights	18
A 20-year review comparing the use of ‘schizophrenia’ and ‘psychosis’ in UK newspapers from 2000 to 2019: Implications for stigma reduction	18
Unraveling schizophrenia's genetic complexity through advanced causal inference and chromatin 3D conformation	18
Long-term safety and effectiveness of open-label lurasidone in antipsychotic-Naïve versus previously treated adolescents with Schizophrenia: A post-hoc analysis	18
Risks and benefits of clozapine and lithium co-prescribing: A systematic review and expert recommendations	17
Relationship between cognition and suicidal behavior in recent-onset psychosis	17
Potential mechanisms between psychotic-like experiences and suicidal ideation in the context of COVID-19: A longitudinal study	17
Blunted pupil light reflex is associated with negative symptoms and working memory in individuals with schizophrenia	17
Temporal variation in the incidence of treated psychotic disorders in young people	17
Schizotypy unfolding into the night? Schizotypal traits and daytime psychotic-like experiences predict negative and salient dreams	17
Association between initial clozapine titration and pneumonia risk among patients with schizophrenia in a Korean tertiary hospital	17
Cognitive training for schizophrenia: Do race and ethnicity matter?	17
Editorial Board	17
CSF dopamine is elevated in first-episode psychosis and associates to symptom severity and cognitive performance	17
Associations between the urban environment and psychotic experiences in adolescents	17
Core clinical manifestations of clozapine-related DRESS syndrome: A network analysis	17
Deconstructing emotion regulation in schizophrenia: The nature and consequences of abnormalities in monitoring dynamics	17
Gross anatomical variations of the insular cortex in first-episode schizophrenia	17
Increasing social and community participation in veterans living with schizophrenia: A treatment outcome study	16
Randomized, sham-controlled trial of transcranial magnetic stimulation augmentation of cognitive remediation in schizophrenia	16
Re-inventing the schizophrenia syndrome: The elusive “theory of everything”	16
Holding onto the center: Lived experience and the construct of schizophrenia	16
Multimorbidity landscape of schizophrenia: Insights from meta-analysis of genome wide association studies	16
Are patients with schizophrenia treated less with second-line glucose-lowering drugs for type 2 diabetes?	16
The schizophrenia concept	16
Agreement on the contours of schizophrenia: The first order of business	16
Exploring the conceptualisation, measurement, clinical utility and treatment of formal thought disorder in psychosis: A Delphi study	16
Dual diagnosis theater: A pilot drama therapy program for individuals with serious mental illness and substance use disorder	15
Reflections on the nature of measurement in language-based automated assessments of patients' mental state and cognitive function	15
Philosophy in psychiatry: Sparking a renaissance of individuality- authors reply to the comment of Trino and Laura Baptista	15
Autism-spectrum quotient mediates the relationship between clinical symptoms and quality of life in schizophrenia	15
Profiles and trajectories of mental health service utilisation during early intervention in psychosis	15
A connectome-wide association study of altered functional connectivity in schizophrenia based on resting-state fMRI	15
Association of CACNA1C polymorphisms (rs1006737, rs4765905, rs2007044) with schizophrenia: A meta-analysis and trial sequential analysis	15
Computerized or manual? Long term effects of cognitive remediation on schizophrenia	15
Searching for the “final proof” of schizophrenia	15
Gut microbial changes of patients with psychotic and affective disorders: A systematic review	15
Human endogenous retroviruses type W (HERV-) activation and schizophrenia: A meta-analysis	15
Gender differences in first episode psychosis: Some arguments to develop gender specific treatment strategies	14
Does metacognitive training for psychosis (MCT) improve neurocognitive performance? A systematic review and meta-analysis	14
Everyday function in schizophrenia: The impact of aerobic endurance and skeletal muscle strength	14
Correlates of hearing loss among adults with schizophrenia	14
A digital tool for self-assessment of auditory verbal hallucinations in schizophrenia	14
Early cognitive development and psychopathology in children at familial high risk for schizophrenia	14
Antipsychotic dopamine D2 affinity and negative symptoms in remitted first episode psychosis patients	14
Optimizing recovery in first-episode psychosis: A systematic review of psychosocial interventions	14
Applicability and future status of schizophrenia as a construct in Africa	14
Neural circuit disruptions of eye gaze processing in autism spectrum disorder and schizophrenia: An activation likelihood estimation meta-analysis	14
Occasional cannabis use is associated with higher premorbid functioning and IQ in youth at clinical high-risk (CHR) for psychosis: Parallel findings to psychosis cohorts	14
App for independence: A feasibility randomized controlled trial of a digital health tool for schizophrenia spectrum disorders	14
Effects of paranoia on well-being in adolescents: A longitudinal mediational analysis	14
Is our mistake trying to identify a “homogeneous” schizophrenia construct?	14
Testing two theories of social support benefits and implications for individuals with psychotic-like experiences	13
Association between serum insulin-like growth factor 1 levels and the improvements of cognitive impairments in a subgroup of schizophrenia: Preliminary findings	13
The effect of prednisolone on symptom severity in schizophrenia: A placebo-controlled, randomized controlled trial	13
Bazett's correction formula overestimates the corrected QT among patients with antipsychotic induced tachycardia	13
Highlights in this issue	13
Unpacking the phenomenon of declining transition rates to first episode psychosis: The dyad of science and service reform in action	13
Creatine kinase levels among asymptomatic patients with severe mental illnesses: A complex baseline for an important clinical biomarker	13
Complement C4 associations with altered microbial biomarkers exemplify gene-by-environment interactions in schizophrenia	13
Incidence, prevalence, and trajectories of suicidal ideation among clients enrolled in early intervention services for first episode psychosis in New York State	13
Peripheral and central biomarkers associated with inflammation in antipsychotic naïve first episode psychosis: Pilot studies	13
Impact of cognitive remediation on the prediction of employment outcomes in severe mental illness	13
Cortical morphometric correlational networks associated with cognitive deficits in first episode schizophrenia	13
An opportunity for primary prevention research in psychotic disorders	12
Adult outcome of preterm birth: Implications for neurodevelopmental theories of psychosis	12
Cortical gray matter reduction precedes transition to psychosis in individuals at clinical high-risk for psychosis: A voxel-based meta-analysis	12
Investigating the diagnostic utility of speech patterns in schizophrenia and their symptom associations	12
Electroconvulsive therapy in a patient with positive anti-NMDA receptor antibodies presenting with isolated psychiatric symptoms: A case report	12
How far to go in deconstructing negative symptoms? Behavioural and neural level evidence for the amotivation domain	12
Adherence to recommended health and social distancing precautions during the COVID-19 pandemic in individuals with schizophrenia and youth at clinical high-risk for psychosis	12
Network signatures of rTMS treatment in patients with schizophrenia and auditory verbal hallucination during an auditory-motor task using HD-EEG	12
Lower functional connectivity of white matter during rest and working memory tasks is associated with cognitive impairments in schizophrenia	12
Social cognition and self-reported ASD traits in young adults who have reported psychotic experiences: A population-based, longitudinal study	12
Omega-3 fatty acids reduce cardiometabolic risk in first-episode schizophrenia patients treated with antipsychotics: Findings from the OFFER randomized controlled study	12
Middle temporal corpus callosum impairment as a predictor of eight-week treatment outcome of drug-naïve first-episode psychosis patients: A pilot longitudinal study	12
Towards DSM 10: A bio-classification of developmental schizophrenia?	12
A brief psychometric test reveals robust shape completion deficits in schizophrenia that are less severe in bipolar disorder	12

Deconstruction of a screening questionnaire for prodromal psychosis to reduce false positive responses	12
Advanced paternal age and risk of schizophrenia in offspring – Review of epidemiological findings and potential mechanisms	12
A nationwide study of the risk of all-cause, sudden death, and cardiovascular mortality among antipsychotic-treated patients with schizophrenia in Taiwan	12
Psychophysiological stress-reactivity in clinical and non-clinical voice-hearers	12
Differences in psychosocial functioning between psychotic disorders in the Finnish SUPER study	12
Extended gene set analysis of human neuro-psychiatric traits shows enrichment in brain-expressed human accelerated regions across development	12
Speech markers to predict and prevent recurrent episodes of psychosis: A narrative overview and emerging opportunities	11
A naturalistic cohort study of first-episode schizophrenia spectrum disorder: A description of the early phase of illness in the PSYSCAN cohort	11
Increased likelihood of distressing and functionally impairing psychotic-like experiences among children with co-occurring internalising and externalising problems	11
Memantine treats psychosis and agitation associated with Moderna COVID-19 vaccine	11
Coordinated specialty care for first-episode psychosis: Effects on social motivation and social pleasure	11
Means of suicide among adults with schizophrenia across the life span	11
Prevalence and 3-year incidence of physical illnesses after schizophrenia diagnosis: Comparison with general population	11
Thought and language disorder as a possible endophenotype in schizophrenia: Evidence from patients and their unaffected siblings	11
The influence of comorbid disease on premature death due to natural and unnatural causes in persons with schizophrenia	11
Effect of add-on tDCS therapy for auditory hallucinations on frequency and duration deviant mismatch negativity in schizophrenia	11
The impact of daily social support on the associations between daily negative events and daily suspiciousness across different clinical stages of psychosis	11
Factors impacting intent to seek treatment within youth at clinical high risk for psychosis	11
Substance use and self-poisoning in schizophrenia: 11-year findings from a national clinical survey of suicide in mental health patients in the UK	11
Pilot study indicates that a gluten-free diet lowers oxidative stress for gluten-sensitive persons with schizophrenia	11
Automated linguistic analysis in speech samples of Turkish-speaking patients with schizophrenia-spectrum disorders	11
Characteristics and clinical correlates of risk symptoms in individuals at clinical high-risk for psychosis: A systematic review and meta-analysis	11
Clinical insights: Preventing psychosis treatment disengagement	11
National trends in metabolic risk of psychiatric inpatients in the United States during the atypical antipsychotic era	11
Ethno-racial variation in psychotic experiences in the United States: Findings from the National Latino and Asian American Survey and the National Survey of American Life	11
Intensity-dependent modulation of the early auditory gamma-band response in first-episode schizophrenia and its association with disease symptoms	11
Victimization in schizophrenia and its relation to violence	11
Sociodemographic and clinical correlates of hallucinations in patients entering an early intervention program for first episode psychosis	11
Defeatist performance beliefs in individuals with recent-onset schizophrenia: Relationships with cognition and negative symptoms	11
Effect of treatment with paliperidone palmitate versus oral antipsychotics on frontal lobe intracortical myelin volume in participants with recent-onset schizophrenia: Magnetic resonance imaging resul	11
Assessing the diametrical model of schizotypal and autistic traits in emotion recognition and social functioning in a community sample	11
Examining delusional ideation: Relationships with race and socioeconomic status	11
Prior overweighting relates to delusional ideation in individuals at clinical high-risk for psychosis	11
Relationship between cortical glutamatergic metabolite levels and hippocampal activity in schizotypy	11
Associations between interpersonal trauma and social impairments in adolescents with and without a family history of psychosis	11
Associations between acceptance of the implausible bias, theory of mind and delusions in first-episode psychosis patients; A longitudinal study	11
Exploring peripheral biomarkers of response to simvastatin supplementation in schizophrenia	11
Shortening telomere is associated with psychotic dimensions in the general population	11
Changes in sedative burden at discharge in hospitalised patients experiencing psychotropic polypharmacy	11
Elevated triglycerides and low triiodothyronine: Key risk factors for coronary artery calcification in patients with schizophrenia	11
Extension, translation and preliminary validation of the Northoff Scale for Subjective Experience in Catatonia (NSSC)	11
Insomnia and cardiovascular disease risk in schizophrenia	11
Probing the biological consequences of a previously undescribed de novo mutation of ZMYND11 in a schizophrenia patient by CRISPR genome editing and induced pluripotent stem cell based in vitro disease	10
Trends in socioeconomic inequalities in incidence of severe mental illness – A population-based linkage study using primary and secondary care routinely collected data between 2000 and 2017	10
‘Are these my thoughts?’: A 20-year prospective study of thought insertion, thought withdrawal, thought broadcasting, and their relationship to auditory verbal hallucinations	10
Frequency of clinical appointments in subjects with emergent suicidal ideation	10
Reinventing schizophrenia – Embracing complexity and complication	10
A polymorphism in the glutamate metabotropic receptor 7 is associated with cognitive deficits in the early phases of psychosis	10
Bidirectional Mendelian randomization to explore the causal relationships between schizophrenia and narcolepsy	10
Personality traits and coping strategies in recent-onset psychosis: Associations with symptom severity and psychosocial functioning	10
Measurement invariance of the Revised-Green Paranoid Thought Scale across Black and White Americans	10
Aggressive behaviors in first-episode psychosis: Distinction between the premorbid phase and the onset of psychosis	10
The associations between attenuated psychosis symptoms and functioning in Black and White youth at clinical high-risk for psychosis	10
Schizophrenia construct: Quandaries and conundrums in India and LAMIC	10
Discrimination, psychotic experiences, and racial identity among Black Americans: Findings from the National Survey of American Life	10
Human stem cell-based models to study synaptic dysfunction and cognition in schizophrenia: A narrative review	10
Incidence and outcome of COVID-19 in patients with schizophrenia: A Study from India	10
Premorbid adjustment in childhood is associated with later emotion management in first-episode schizophrenia	10
Revealing the reporting disparity: VigiBase highlights underreporting of clozapine in other Western European countries compared to the UK	10
Normal-range verbal memory in the first-episode of psychosis: Clinical and functional outcomes across 24 months and impact of estimated verbal memory decrement	10
Computational modeling of excitatory/inhibitory balance impairments in schizophrenia	10
Medical cannabis authorization and risk of emergency department visits and hospitalization due to psychotic disorders: A propensity score-matched cohort study	10
Pseudoneurotic symptoms in the schizophrenia spectrum: An empirical study	10
The long-lasting impact of high-intensity training via collaborative care in patients with schizophrenia: A 5-year follow-up study	10
The flickering spotlight of visual attention: Characterizing abnormal object-based attention in schizophrenia	10
Childhood trauma exposure and personality traits in schizophrenia patients	10
Betaine supplementation improves positive symptoms in schizophrenia	10
Comments on the manuscript: Arthur Schopenhauer: An underappreciated philosopher in psychiatry and his applied epistemology of body and self-experience	10
Increased immune cell and altered microglia and neurogenesis transcripts in an Australian schizophrenia subgroup with elevated inflammation	10
Thalamic and striato-pallidal volumes in schizophrenia patients and individuals at risk for psychosis: A multi-atlas segmentation study	10
Subclinical schizotypal vs. autistic traits show overlapping and diametrically opposed facets in a non-clinical population	10
Altered central vision and amacrine cells dysfunction as marker of hypodopaminergic activity in treated patients with schizophrenia	10
Reduced neural activity when anticipating social versus nonsocial rewards in schizophrenia: Preliminary evidence from an ERP study	10
Social victimization, default mode network connectivity, and psychotic-like experiences in adolescents	10
Characteristics of incident substance-induced psychosis compared to first-episode psychotic disorders: A nationwide register-linkage study from Sweden	10
Clozapine and its protective effect on all-cause, natural, and suicide mortality in patients with schizophrenia: A nationwide cohort study in Taiwan	10
Psychotic symptomatology and medication adherence in patients with schizophrenia: The mediating effect of awareness of mental disorder	10
The origins of catatonia – Systematic review of historical texts between 1800 and 1900	10
Influence of time to clozapine prescription on the clinical outcome	10
Toward personalized medicine in schizophrenia: Genetics and epigenetics of antipsychotic treatment	10
Risk of microdosing in clinical high-risk populations	9
Exacerbation of paranoia-like thoughts following exposure to common misophonia trigger sounds	9
Denial of anosognosia in schizophrenia	9
Who wants more social contacts? A cross-sectional study of people with psychotic disorders in England	9
Psychosocial predictors of distressing unusual experiences in adolescence: Testing the fit of an adult cognitive model of psychosis	9
Deep learning model using retinal vascular images for classifying schizophrenia	9
Antisaccade error rates in first-episode psychosis, ultra-high risk for psychosis and unaffected relatives of schizophrenia: A systematic review and meta-analysis	9
Associations of sexual orientation with symptom profiles in first-episode schizophrenia spectrum disorders	9
Accelerated aging in the brain, epigenetic aging in blood, and polygenic risk for schizophrenia	9
Antipsychotic-based machine learning models may help prediction of tardive dyskinesia in patients with schizophrenia	9
The expression of immune related genes and potential regulatory mechanisms in schizophrenia	9
Orientation-dependent contextual modulation of contrast in schizophrenia	9
Relationship between cannabis use and psychotic experiences in college students	9
Interpersonal distance in schizophrenia: A systematic review	9
Changes in degree centrality and its associated genes: A longitudinal study of patients with schizophrenia undergoing pharmacological treatment	9